| 0.153 0.003 (1.93%) | 05-01 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 0.22 | 1-year : | 0.25 |
| Resists | First : | 0.19 | Second : | 0.21 |
| Pivot price | 0.16 |
|||
| Supports | First : | 0.15 | Second : | 0.12 |
| MAs | MA(5) : | 0.15 |
MA(20) : | 0.16 |
| MA(100) : | 0.19 |
MA(250) : | 0.46 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 5.3 |
D(3) : | 10.1 |
| RSI | RSI(14): 39.2  |
|||
| 52-week | High : | 1.02 | Low : | 0.15 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AFIB ] has closed above bottom band by 4.1%. Bollinger Bands are 59.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.16 - 0.16 | 0.16 - 0.16 |
| Low: | 0.15 - 0.15 | 0.15 - 0.15 |
| Close: | 0.15 - 0.15 | 0.15 - 0.15 |
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Wed, 03 Apr 2024
Acutus Medical Full Year 2023 Earnings: US$0.41 loss per share (vs US$1.40 loss in FY 2022) - Simply Wall St
Sat, 24 Feb 2024
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding - Simply Wall St
Fri, 09 Feb 2024
Acutus Medical Faces Biotronik Contract Termination Dispute - TipRanks.com - TipRanks
Thu, 25 Jan 2024
Why IBM Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - Acutus Medical (NASDA - Benzinga
Thu, 09 Nov 2023
Medtronic's Manufacturing Partner Acutus Medical Exits Electrophysiology Mapping, Ablation Businesses - A - Benzinga
Wed, 08 Nov 2023
Acutus Medical Inc (AFIB) Reports Substantial Revenue Growth in Q3 2023 Despite Negative Gross Margin - GuruFocus.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 30 (M) |
| Shares Float | 23 (M) |
| Held by Insiders | 3.5 (%) |
| Held by Institutions | 23.5 (%) |
| Shares Short | 845 (K) |
| Shares Short P.Month | 1,470 (K) |
| EPS | -0.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.03 |
| Profit Margin | 0 % |
| Operating Margin | -288.8 % |
| Return on Assets (ttm) | -13.9 % |
| Return on Equity (ttm) | -32.2 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.24 |
| EBITDA (p.s.) | -0.69 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -63 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -0.38 |
| PEG Ratio | 0 |
| Price to Book value | -5.1 |
| Price to Sales | 0.63 |
| Price to Cash Flow | -0.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|